...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Exempt Distribution
Reply New Message
Back To Forum List View
Icon president Exempt Distribution
8
RVXoldtimer
Feb 17, 2021 02:51PM
Re: Exempt Distribution
1
KOO-KOO2
Feb 19, 2021 09:10AM

The only thing i can think of is DM may have pending deal close in  hand since Zenith E is private he can reveal more details to potential investors.....  I doubt it though,  

1 Recommendations
Re: Exempt Distribution
2
Telepanel
Feb 19, 2021 02:17PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply